key: cord-0768539-amalp1pt
authors: Arora, Aakanksha; Mohta, Alpana; Ghiya, Bhikam Chand; Kumar Jangir, Vishnu
title: Acute postinfectious type III pityriasis rubra pilaris as a cutaneous manifestation in COVID‐19: Decoding a possible trigger!!
date: 2022-04-09
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14933
sha: 2b58726d95752a6342216b6d8622743b93e0c335
doc_id: 768539
cord_uid: amalp1pt

nan

To the Editor,

The clinical spectrum of COVID-19-induced skin manifestations in the literature includes urticarial rash, maculopapular rash, morbilliform rash, papulovesicular exanthem, chilblain-like acral pattern, livedo reticularis/racemosa-like pattern, and purpuric "vasculitic" pattern. 1 Pityriasis rubra pilaris (PRP) is a rare, idiopathic inflammatory papulosquamous disorder. Infection, autoimmunity, drugs, and malignancies can be triggers for PRP. 2 Herein, we report a pediatric case of pityriasis rubra pilaris post-COVID-19 infection. In conclusion, the association between COVID-19 and PRP may not be just coincidental because viral agents have been proposed to be a trigger in PRP pathogenesis. Further research is needed to confirm the correlation between SARS-CoV-2 infection and PRP.

Due ethical approval was taken from institutional ethics committee.

The patient gave written informed consent to be a part of this study.

Data sharing is not applicable to this article as no new data were created or analyzed in this study. 

Skin manifestations associated with COVID-19: current knowledge and future perspectives

Juvenile) Pityriasis rubra pilaris

Pityriasis rubra pilaris: algorithms for diagnosis and treatment

Acute pityriasis rubra pilaris in childhood. Four cases

Acute postinfectious pityriasis rubra pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features

Pityriasis rubra pilaris post-infection due COVID-19: case report